Acute Promyclocytic Leukemic is a distinct subtype of acturte myeloid leukemia associated with a reciprocal translocation which always involves chromosome 17 ana variably involves chromosomes 15, 11 or 5. At the molecular levekm tge breakpoints lie within the RARalpha locus on chromosomes 17, the PNL gave on 15, the PLZF gene on 11 and the NFM gene on chromosome 5. The investigator hypothesizes that the PML/RARalpha, PLZF/RARalpha and NFM/RARalpha fusion proteins act in a dominant negative manner the distruct the normal function of RARalpha/PLZF as well as aberrant P products cooperate synergistically leading to leukemia. He proposes to test the above hypothesis in vivo by a direct genetic approach with the following Specific Aims: 1) To define the leukemogenic role of individual APL specifi fusion proteins by generating transgenic mice in which the expression of these molecules is restricted to the hemopoietic/myeloid cellular compartment. Hemopoiesis of the transgenes will be analyzed to disclose the leukemogenic potential of the infividual fusion molecules. In addition, the various transgenes will be intercrossed to reproduce in vivo the genetic complexity observed in the APL blast, and to elucidate the possible cooperative roles of these molecules in the full blown leukemia. 2) To establish the role of PML, PLZF, NPM and RARalpha in APL promotion and progression. To this end, he will interbreed the various transgenes with their respective knockout mice in order to generate transgenes for the fusion molecules in a PML, PLZF and RARalpha +/- and -/- genetic background, and will interbreed the various knockout mice with each other. Hemopoiesis and leukemogenesis in the resulting transgene combinaiton will be analyzed on a comparative basis. p

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA074031-01
Application #
2012028
Study Section
Pathology B Study Section (PTHB)
Project Start
1997-06-01
Project End
2000-05-31
Budget Start
1997-06-01
Budget End
1998-05-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Khanna-Gupta, Arati; Abayasekara, Nirmalee; Levine, Michelle et al. (2012) Up-regulation of translation eukaryotic initiation factor 4E in nucleophosmin 1 haploinsufficient cells results in changes in CCAAT enhancer-binding protein ? activity: implications in myelodysplastic syndrome and acute myeloid leukemia. J Biol Chem 287:32728-37
Carracedo, Arkaitz; Ito, Keisuke; Pandolfi, Pier Paolo (2011) The nuclear bodies inside out: PML conquers the cytoplasm. Curr Opin Cell Biol 23:360-6
Cheng, Ke; Sportoletti, Paolo; Ito, Keisuke et al. (2010) The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model. Blood 115:3341-5
Lin, Hui-Kuan; Wang, Guocan; Chen, Zhenbang et al. (2009) Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol 11:420-32
Ito, Keisuke; Bernardi, Rosa; Pandolfi, Pier Paolo (2009) A novel signaling network as a critical rheostat for the biology and maintenance of the normal stem cell and the cancer-initiating cell. Curr Opin Genet Dev 19:51-9
Rego, E M; Ruggero, D; Tribioli, C et al. (2006) Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha. Oncogene 25:1974-9
Shen, Tian Huai; Lin, Hui-Kuan; Scaglioni, Pier Paolo et al. (2006) The mechanisms of PML-nuclear body formation. Mol Cell 24:331-9
Matsushita, Hiromichi; Scaglioni, Pier Paolo; Bhaumik, Mantu et al. (2006) In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia. J Exp Med 203:821-8
Gurrieri, Carmela; Capodieci, Paola; Bernardi, Rosa et al. (2004) Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 96:269-79
Sukhai, Mahadeo A; Wu, Xuemei; Xuan, Yali et al. (2004) Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARalpha. Oncogene 23:665-78

Showing the most recent 10 out of 19 publications